GlassScriptPhysician profile
Mieke D Lane
NPI 1356390454
$488.89
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $71.03 · 2021: $39.38 · 2022: $77.75 · 2023: $70.74 · 2024: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $174.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $94.95 | 2019-2022 | |
| Astellas Pharma US INC | $92.89 | 2023-2024 | Veozah |
| Abbvie INC. | $57.24 | 2019-2021 | |
| Coopersurgical, INC. | $34.34 | 2019-2024 | Summit Doppler |
| Daiichi Sankyo INC. | $32.89 | 2022-2023 | Injectafer |
| Amag Pharmaceuticals, INC. | $32.53 | 2019-2020 | |
| Merz North America, INC. | $26.94 | 2019 | |
| Hologic Sales and Service, LLC | $23.57 | 2024 | Thinprep 2000 Processor |
| Therapeuticsmd, INC. | $22.96 | 2021 | |
| Medtronic, INC. | $20.51 | 2023 | Venaseal |
| Biohaven Pharmaceutical Holding Company LTD. | $18.78 | 2022 | |
| Pfizer INC. | $16.98 | 2022 | |
| Allergan, INC. | $14.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mieke Lane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.